Vertex Planning Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Buy
6,815
+34
+0.5% +$10.1K 0.39% 44
2025
Q4
$1.85M Sell
6,781
-183
-3% -$49.7K 0.43% 39
2025
Q3
$1.88M Buy
6,964
+7
+0.1% +$1.91K 0.36% 50
2025
Q2
$1.92M Buy
6,957
+16
+0.2% +$4.35K 0.4% 49
2025
Q1
$1.84M Buy
6,941
+63
+0.9% +$15.5K 0.4% 44
2024
Q4
$1.6M Buy
+6,878
New +$1.58M 0.35% 47

Other funds holding CME

Vertex Planning Partners's CME Position: Q1 2026 in Review

Vertex Planning Partners increased its CME Group (CME) stake by 0.5% in Q1 2026, buying an estimated $10.1K and bringing the position to 6,815 shares worth $2.01M. The position accounts for 0.39% of the portfolio, ranked #44.

Vertex Planning Partners first reported a position in CME in Q4 2024 and has held it in 6 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Vertex Planning Partners held 6,815 shares of CME Group worth $2.01M as of Q1 2026.
  • Vertex Planning Partners bought 34 CME Group shares in Q1 2026, an estimated $10.1K.
  • CME Group made up 0.39% of Vertex Planning Partners's portfolio in Q1 2026, its #44 holding.
  • Vertex Planning Partners first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Vertex Planning Partners's 13F filing for Q1 2026, filed 15 May 2026.